Skip to content
Guess what? Valuesider just got better: smarter and more intuitive.
User

B. Tweedy, Ch. Browne

Tweedy, Browne Co All Funds (US)

Tweedy, Browne Co All Funds (US) Johnson & Johnson stake

total: 174

Tweedy, Browne Co All Funds (US) JNJ trades

Total transactions:
52
New positions:
1
Reduced:
51
Held since:
2013 Q2 or earlier
Held for:
52+ quarters
Latest activity:
2026 Q1
According to 2026 Q1 report, Tweedy, Browne Co All Funds (US) holds 219,490 Johnson & Johnson (JNJ) shares with a market value of roughly $53.65M accounting for 4.26% of the overall portfolio. Tweedy, Browne Co All Funds (US) has held JNJ since at least 2013 Q2 with about 4.34M shares in our earliest available record. Since at least 2013 Q2, Tweedy, Browne Co All Funds (US) has made 51 more transactions.

How many JNJ shares does Tweedy, Browne Co All Funds (US) currently hold?

According to 2026 Q1 report, Tweedy, Browne Co All Funds (US) holds 219,490 shares of Johnson & Johnson (JNJ), valued at around $53.65M.

Estimated cost basis*

Weighted AVG buy price:
$85.86
Weighted AVG sell price:
$135.50

Tweedy, Browne Co All Funds (US)'s historical trades in Johnson & Johnson

52 results
Period % of
portfolio
Shares
held after*
Reported
price*
Value* % (shares)
of activity
% change
to portfolio
2026 Q1
4.26%
219,490
$244.44
$53,652,136
-7.03% (-16,585)
-0.33%
2025 Q4
3.94%
236,075
$206.95
$48,855,721
-2.45% (-5,928)
-0.11%
2025 Q3
3.90%
242,003
$185.42
$44,872,196
-1.11% (-2,710)
-0.05%
2025 Q2
3.47%
244,713
$152.75
$37,379,911
-44.16% (-193,558)
-2.62%
2025 Q1
6.44%
438,271
$165.84
$72,682,863
-59.44% (-642,200)
-7.18%
2024 Q4
10.53%
1,080,471
$144.62
$156,257,716
-4.06% (-45,711)
-0.32%
2024 Q3
8.70%
1,126,182
$162.06
$182,509,055
-0.38% (-4,280)
-0.03%
2024 Q2
7.60%
1,130,462
$146.16
$165,228,326
-0.29% (-3,263)
-0.02%
2024 Q1
8.42%
1,133,725
$158.19
$179,343,958
-0.12% (-1,393)
-0.01%
2023 Q4
8.68%
1,135,118
$156.74
$177,918,395
-0.46% (-5,244)
-0.04%
2023 Q3
9.50%
$155.75
-5.71% (-69,034)
2023 Q2
10.51%
$165.52
-1.82% (-22,387)
2023 Q1
10.39%
$155.00
-0.15% (-1,813)
2022 Q4
11.60%
$176.65
-17.14% (-255,224)
2022 Q3
10.71%
$163.36
-0.22% (-3,326)
2022 Q2
10.83%
$177.51
-4.58% (-71,690)
2022 Q1
8.95%
$177.23
-6.19% (-103,113)
2021 Q4
9.05%
$171.07
-0.46% (-7,777)
2021 Q3
9.04%
$161.50
-3.21% (-55,474)
2021 Q2
8.01%
$164.74
-1.86% (-32,752)
2021 Q1
8.43%
$164.35
-1.52% (-27,135)
2020 Q4
8.75%
$157.38
-0.70% (-12,639)
2020 Q3
10.40%
$148.88
-2.11% (-38,871)
2020 Q2
10.33%
$140.63
-1.35% (-25,173)
2020 Q1
11.36%
$131.13
-5.14% (-101,134)
2019 Q4
10.38%
$145.87
-3.71% (-75,820)
2019 Q3
9.36%
$129.38
-0.16% (-3,255)
2019 Q2
10.07%
$139.28
-0.46% (-9,392)
2019 Q1
9.48%
$139.79
-3.53% (-75,353)
2018 Q4
9.74%
$129.05
-0.37% (-7,868)
2018 Q3
8.91%
$138.17
-1.73% (-37,557)
2018 Q2
8.21%
$121.34
-2.00% (-44,366)
2018 Q1
8.72%
$128.15
-1.19% (-26,736)
2017 Q4
8.61%
$139.72
-1.93% (-44,303)
2017 Q3
8.11%
$130.01
-0.28% (-6,465)
2017 Q2
9.03%
$132.29
-2.92% (-69,248)
2017 Q1
8.47%
$124.55
-0.77% (-18,295)
2016 Q4
8.59%
$115.21
-19.88% (-592,221)
2016 Q3
10.59%
$118.13
-7.39% (-237,730)
2016 Q2
10.95%
$121.30
-4.93% (-166,932)
2016 Q1
10.08%
$108.20
-8.39% (-309,904)
2015 Q4
11.14%
$102.72
-4.22% (-162,587)
2015 Q3
10.72%
$93.35
-1.60% (-62,865)
2015 Q2
10.55%
$97.46
-3.38% (-137,161)
2015 Q1
11.01%
$100.60
-2.09% (-86,483)
2014 Q4
11.09%
$104.57
-0.52% (-21,489)
2014 Q3
10.22%
$106.59
-0.77% (-32,290)
2014 Q2
9.38%
$104.62
-1.71% (-72,982)
2014 Q1
9.66%
$98.23
-0.85% (-36,725)
2013 Q4
9.17%
$91.59
-0.42% (-18,200)
2013 Q3
9.01%
$86.69
-0.35% (-15,013)
2013 Q2
9.31%
$85.86
new or own*
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.